Nuveen’s AnaptysBio ANAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$17.5M Sell
316,065
-620
-0.2% -$33.4K ﹤0.01% 1215
2025
Q4
$15.4M Sell
316,685
-22,586
-7% -$880K ﹤0.01% 1299
2025
Q3
$10.4M Buy
339,271
+15,737
+5% +$361K ﹤0.01% 1527
2025
Q2
$7.18M Buy
323,534
+267,522
+478% +$5.6M ﹤0.01% 1703
2025
Q1
$1.04M Hold
56,012
﹤0.01% 2630
2024
Q4
$742K Hold
56,012
﹤0.01% 2831
2024
Q3
$1.88M Hold
56,012
﹤0.01% 2441
2024
Q2
$1.4M Sell
56,012
-8,228
-13% -$192K ﹤0.01% 2558
2024
Q1
$1.45M Buy
64,240
+11,126
+21% +$263K ﹤0.01% 2542
2023
Q4
$1.14M Sell
53,114
-19,452
-27% -$336K ﹤0.01% 2677
2023
Q3
$1.3M Buy
72,566
+159
+0.2% +$3.03K ﹤0.01% 2465
2023
Q2
$1.47M Sell
72,407
-3,808
-5% -$77.2K ﹤0.01% 2488
2023
Q1
$1.66M Sell
76,215
-83,479
-52% -$2.03M ﹤0.01% 2416
2022
Q4
$4.95M Sell
159,694
-68,088
-30% -$1.92M ﹤0.01% 1908
2022
Q3
$5.81M Sell
227,782
-24,022
-10% -$563K ﹤0.01% 1815
2022
Q2
$5.11M Sell
251,804
-160,843
-39% -$3.56M ﹤0.01% 1919
2022
Q1
$10.9M Sell
412,647
-484
-0.1% -$14.6K ﹤0.01% 1582
2021
Q4
$14.4M Sell
413,131
-7,818
-2% -$248K ﹤0.01% 1449
2021
Q3
$11.4M Buy
420,949
+12,593
+3% +$320K ﹤0.01% 1688
2021
Q2
$10.6M Buy
408,356
+30,649
+8% +$735K ﹤0.01% 1832
2021
Q1
$8.14M Buy
377,707
+220,383
+140% +$5.56M ﹤0.01% 1910
2020
Q4
$3.38M Sell
157,324
-68,280
-30% -$1.66M ﹤0.01% 2254
2020
Q3
$3.33M Sell
225,604
-5,539
-2% -$99.9K ﹤0.01% 2129
2020
Q2
$5.16M Buy
231,143
+7,538
+3% +$138K ﹤0.01% 1881
2020
Q1
$3.16M Buy
223,605
+30,128
+16% +$457K ﹤0.01% 1958
2019
Q4
$3.14M Buy
193,477
+94,212
+95% +$2.23M ﹤0.01% 2232
2019
Q3
$3.47M Sell
99,265
-88
-0.1% -$4.19K ﹤0.01% 2144
2019
Q2
$5.61M Buy
+99,353
New +$7.15M ﹤0.01% 1919

Other funds holding ANAB